Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108976129B reveals a cost-effective synthesis for Flumioxazin intermediates, offering high purity and scalable production for global agrochemical supply chains.
Patent CN101765579A reveals a safer, high-yield route for beta-nitrostyrene compounds using primary amines. Discover cost-effective manufacturing solutions for pharmaceutical intermediates.
Novel patent CN106518862A details high-purity impurity synthesis. Enables reliable supply chain and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN101765579A details a safe acetic acid method for beta-nitrostyrene. Offers cost reduction in pharma intermediate manufacturing with high purity.
Patent CN113999270B reveals a high-yield route for CDP synthesis using dichlorophosphoryl morpholine, offering significant cost reduction and scalability for nucleoside manufacturing.
Patent CN108409818B reveals a high-yield cytidine synthesis route eliminating tin tetrachloride. Discover cost-effective manufacturing and supply chain advantages for nucleoside intermediates.
Discover a high-purity Solifenacin Succinate synthesis method using ionic liquids. Achieve >99.8% purity with scalable, cost-effective pharmaceutical intermediate manufacturing.
Novel Fe-catalyzed alkene oxidation method replaces Pd. High yield up to 98%. Eco-friendly route for pharmaceutical intermediates manufacturing.
Patent CN108083999B details a visible-light catalyzed route for alpha-hydroxy ketones, offering cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Novel domino reaction method for spiroindoline tetrabenzofuran. High yield, scalable process for pharmaceutical intermediates.
Advanced synthesis of alkyl diphenylphosphine via patent CN105111235B. Delivers high-purity ligands and supply chain efficiency for global catalyst manufacturing.
Novel patent CN119823114B details a greener thiabendazole synthesis. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN103449946B reveals ammonium salt catalysis for high-purity pharmaceutical intermediates with reduced waste and significant cost efficiency advantages for buyers.
Patent CN115806508B details ionic liquid catalyst for low 2 2 MDI. Enhances purity and supply chain reliability for global polymer and pharma packaging manufacturers.
Patent CN116283543B reveals high-yield chiral glyceric acid production. Biomass conversion offers cost reduction and supply reliability for pharma intermediates.
Patent CN107973703B details a green one-pot synthesis of anethole using aliphatic acetals and solid acid catalysts, offering significant cost reduction and scalability for flavor manufacturers.
Patent CN103373948A details a high-yield 6-step asymmetric synthesis of (-)-Kainic Acid using Rh-catalysis, offering a reliable alternative to natural extraction for neuroscience research.
Patent CN112961088B reveals a C13+C7 Vitamin A Acetate route eliminating triphenylphosphine waste. Discover cost reduction in vitamins manufacturing and high-purity supply.
Novel electrochemical method for beta-arylamino ketones. Green, sustainable, metal-free. Reliable pharmaceutical intermediates supplier.
Patent CN103665057A details a safer bromotetraacetylglucose synthesis. Achieves high purity and cost reduction in pharma manufacturing for glycoside intermediates.